B · Normal
[CITIC Securities: National medical insurance negotiations continue to support innovative drugs and focus on commercialization increases in 2027] On November 16, CITIC Securities research report believes that the national medical insurance negotiations continue to support the policy direction of innovation, and the inclusion of new varieties, expanded indications and in-hospital payment packages will jointly promote commercial growth in 2027. The new version of the catalog announced on November 14, 2026 added 107 new drugs, including 51 Category 1 innovative drugs, the number reached a new high, and CAR-T was included in the basic medical insurance for the first time. This adjustment improves pre-declaration and the transition from commercial insurance to basic medical insurance, further clarifies long-term renewal rules, and promotes the entry of drugs into hospitals and "dual-channel" supply.
Comments